Myriad Genetics
Stock Forecast, Prediction & Price Target
Myriad Genetics Financial Estimates
Myriad Genetics Revenue Estimates
Myriad Genetics EBITDA Estimates
Myriad Genetics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $690.6M N/A | $678.4M -1.76% | $753.2M 11.02% | Avg: $894.33M Low: $894.33M High: $894.33M avg. 18.73% | Avg: $952.19M Low: $952.19M High: $952.19M avg. 6.46% | Avg: $984.63M Low: $984.63M High: $984.63M avg. 3.40% | Avg: $993.78M Low: $993.78M High: $993.78M avg. 0.93% |
Net Income
% change YoY
| $-27.2M N/A | $-112M -311.76% | $-263.3M -135.08% | Avg: $17.24M Low: $17.24M High: $17.24M avg. 106.55% | Avg: $32.60M Low: $32.60M High: $32.60M avg. 89.01% | Avg: $31.40M Low: $31.40M High: $31.40M avg. -3.67% | Avg: $26.05M Low: $26.05M High: $26.05M avg. -17.02% |
EBITDA
% change YoY
| $14.1M N/A | $-67.8M -580.85% | $-186.1M -174.48% | Avg: $-17.66M Low: $-17.66M High: $-17.66M avg. 90.50% | Avg: $-18.80M Low: $-18.80M High: $-18.80M avg. -6.46% | Avg: $-19.44M Low: $-19.44M High: $-19.44M avg. -3.40% | Avg: $-19.62M Low: $-19.62M High: $-19.62M avg. -0.93% |
EPS
% change YoY
| -$0.35 N/A | -$1.39 -297.14% | -$3.18 -128.77% | Avg: $0.21 Low: $0.21 High: $0.21 avg. 106.55% | Avg: $0.39 Low: $0.39 High: $0.39 avg. 89.01% | Avg: $0.38 Low: $0.38 High: $0.38 avg. -3.67% | Avg: $0.31 Low: $0.31 High: $0.31 avg. -17.02% |
Operating Expenses
% change YoY
| $681.7M N/A | $600.1M -11.97% | $774.4M 29.04% | Avg: $685.33M Low: $685.33M High: $685.33M avg. -11.50% | Avg: $729.66M Low: $729.66M High: $729.66M avg. 6.46% | Avg: $754.52M Low: $754.52M High: $754.52M avg. 3.40% | Avg: $761.54M Low: $761.54M High: $761.54M avg. 0.93% |
FAQ
What is Myriad Genetics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 43.71% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 17.24M, average is 17.24M and high is 17.24M.
What is Myriad Genetics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 7.38% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $894.33M, average is $894.33M and high is $894.33M.
What is Myriad Genetics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 43.71% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $0.21, average is $0.21 and high is $0.20.